Literature DB >> 20633620

Evaluation of the anti-inflammatory properties of Dodonaea polyandra, a Kaanju traditional medicine.

Bradley Simpson1, David Claudie, Nick Smith, Jiping Wang, Ross McKinnon, Susan Semple.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Extracts of the medicinal plant species Dodonaea polyandra were investigated as part of a collegial research partnership between Northern Kaanju traditional owners represented by Chuulangun Aboriginal Corporation (centred on the Wenlock and Pascoe Rivers, Cape York Peninsula, Queensland, Australia) and university-based researchers. D. polyandra, known as "Uncha" in Kaanju language, is used in Northern Kaanju Traditional Medicine for relief from pain associated with toothache and related ailments. The species has a restricted distribution in Cape York Peninsula and there has been no previous Western scientific investigation of its pharmacology or chemistry. AIM OF THE STUDY: The current study investigates the anti-inflammatory effects of several extracts from D. polyandra.
MATERIALS AND METHODS: Phytochemical screening was conducted using TLC. Anti-inflammatory effects of leaf extracts were determined using an acute mouse ear oedema model induced by croton oil and 12-o-tetradecanoylphorbol-13-acetate (TPA) chemical irritants.
RESULTS: Flavonoid and terpenoid secondary compounds were detected in leaf extracts of D. polyandra. Non-polar hexane and methylene chloride/methanol extracts showed potent inhibition of inflammation in TPA-induced mouse ear oedema by 72.12 and 79.81%, respectively, after 24 h at 0.4 mg/ear.
CONCLUSION: In a mouse model of acute inflammation, this study revealed that leaf extracts of D. polyandra possess significant anti-inflammatory potential. These results contribute to a Western scientific understanding of the ethnopharmacological use of the plant in Northern Kaanju Medicine for reducing tooth-related pain.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633620     DOI: 10.1016/j.jep.2010.07.012

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  In Vitro Study to Evaluate Antibacterial and Non-haemolytic Activities of Four Iranian Medicinal Plants.

Authors:  S Sepahi; A Ghorani-Azam; S Sepahi; A Asoodeh; S Rostami
Journal:  West Indian Med J       Date:  2014-02-24       Impact factor: 0.171

Review 2.  Indigenous Uses, Phytochemical Analysis, and Anti-Inflammatory Properties of Australian Tropical Medicinal Plants.

Authors:  Karma Yeshi; Gerry Turpin; Tenzin Jamtsho; Phurpa Wangchuk
Journal:  Molecules       Date:  2022-06-15       Impact factor: 4.927

3.  Anti-Inflammatory Effects and Mechanisms of Fatsia polycarpa Hayata and Its Constituents.

Authors:  Hsueh-Ling Cheng; Shi-Yie Cheng; Shen-Da Huang; Yan-Ting Lu; Xiao-Wen Wang; Yu-Liang Liu; Chang-Hung Chou
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-10       Impact factor: 2.629

4.  In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Authors:  Permal Deo; Erandi Hewawasam; Aris Karakoulakis; David J Claudie; Robert Nelson; Bradley S Simpson; Nicholas M Smith; Susan J Semple
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

5.  Anti-Inflammatory Activity of a Polymeric Proanthocyanidin from Serjania schiedeana.

Authors:  David Osvaldo Salinas-Sánchez; Enrique Jiménez-Ferrer; Veronica Sánchez-Sánchez; Alejandro Zamilpa; Manasés González-Cortazar; Jaime Tortoriello; Maribel Herrera-Ruiz
Journal:  Molecules       Date:  2017-05-26       Impact factor: 4.411

6.  Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer.

Authors:  Mohammed S Saddik; Mahmoud M A Elsayed; Mohamed Salaheldin A Abdelkader; Mohamed A El-Mokhtar; Jelan A Abdel-Aleem; Ahmed M Abu-Dief; Mostafa F Al-Hakkani; Hatem S Farghaly; Heba A Abou-Taleb
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.